Global Studies

Collaborating with IBERICA provides Sponsors with exciting options for simultaneous development for the US and Japanese markets. In the early stages of clinical development, IBERICA provides an opportunity to simultaneously conduct PK/PD studies in Japan and the US under the same protocol, with IBERICA’s own data management and biostatistics infrastructure ready to ensure the highest quality in data analysis. (Please refer to Figure 1 below)

Likewise IBERICA also provides its Sponsors with an excellent opportunity to simultaneously conduct PIIa (POC) studies in Japan and the US. (Please refer to Figure 2 below.)